Mishra Deebya R, Shah Divya S, Shah Niharika, Prasad Jagat N, Gupta Pramendra P, Agrawaal Krishna K
Department of Pulmonary, Critical Care and Sleep Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Department of Nephrology, Maharajgunj Medical College, Institute of Medicine, Kathmandu, Nepal.
J Family Med Prim Care. 2020 Dec 31;9(12):6171-6176. doi: 10.4103/jfmpc.jfmpc_1430_20. eCollection 2020 Dec.
Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU) acquired infection among patients receiving mechanical ventilation. Accurate clinical and microbiologic diagnosis of VAP is essential not only for selection of appropriate antimicrobials but also to prevent their misuse. As the organisms and their sensitivity pattern may differ in every ICU, the knowledge of the resident flora and their behaviour should be known for successful treatment.
The study was conducted to evaluate the organisms responsible for VAP and their Antibiotic Sensitivity Pattern for the study setting. A prospective, open, epidemiological clinical study was performed in a tertiary care hospital in Nepal. 100 patients admitted to ICU and Mechanically Ventilated were evaluated about VAP. Clinical Pulmonary Infection Score (CPIS) was used to diagnose VAP.
Among 60 patients ventilated for more than 48 hours, 25 (41.6%) developed VAP. The VAP was caused predominantly by Klebsiella pneumonia in 34.5% of cases, followed by Acinetobacter calcoaceticus baumanni in 27.6%, Acinetobacter wolffi and Pseudomonas aeruginosa in 13.8% each and Escheresia coli in 10.3%. The most sensitive antibiotics were Colistin, followed by Polymyxin B and Amikacin with sensitivity rates of 67%, 60% and 58%, respectively.
Based on these results, an empiric approach to antibiotic treatment can be made tailored to the specific settings. Given the magnitude of drug resistance and its implicated financial and societal burden, there is an urgent need for broad implementation of Antibiotic Stewardship programs across all health care settings.
呼吸机相关性肺炎(VAP)是接受机械通气患者中最常见的重症监护病房(ICU)获得性感染。准确的VAP临床和微生物学诊断不仅对于选择合适的抗菌药物至关重要,而且对于防止其滥用也必不可少。由于每个ICU中的病原体及其敏感性模式可能不同,因此为了成功治疗,应了解常驻菌群及其行为。
本研究旨在评估研究环境中导致VAP的病原体及其抗生素敏感性模式。在尼泊尔的一家三级医院进行了一项前瞻性、开放性、流行病学临床研究。对100名入住ICU并接受机械通气的患者进行了VAP评估。采用临床肺部感染评分(CPIS)诊断VAP。
在60例通气超过48小时的患者中,25例(41.6%)发生了VAP。VAP主要由肺炎克雷伯菌引起,占34.5%的病例,其次是鲍曼不动杆菌,占27.6%,沃氏不动杆菌和铜绿假单胞菌各占13.8%,大肠杆菌占10.3%。最敏感的抗生素是黏菌素,其次是多黏菌素B和阿米卡星,敏感率分别为67%、60%和58%。
基于这些结果,可以针对特定环境制定经验性抗生素治疗方法。鉴于耐药性的严重程度及其带来的经济和社会负担,迫切需要在所有医疗机构广泛实施抗生素管理计划。